rs219779

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001146079.2(CLDN14):​c.243C>T​(p.Arg81=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.243 in 1,613,114 control chromosomes in the GnomAD database, including 50,317 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5073 hom., cov: 33)
Exomes 𝑓: 0.24 ( 45244 hom. )

Consequence

CLDN14
NM_001146079.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.13
Variant links:
Genes affected
CLDN14 (HGNC:2035): (claudin 14) Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. These junctions are comprised of sets of continuous networking strands in the outwardly facing cytoplasmic leaflet, with complementary grooves in the inwardly facing extracytoplasmic leaflet. The protein encoded by this gene, a member of the claudin family, is an integral membrane protein and a component of tight junction strands. The encoded protein also binds specifically to the WW domain of Yes-associated protein. Defects in this gene are the cause of an autosomal recessive form of nonsyndromic sensorineural deafness. It is also reported that four synonymous variants in this gene are associated with kidney stones and reduced bone mineral density. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jun 2010]
CLDN14-AS1 (HGNC:55953): (CLDN14 antisense RNA 1)
LNCTSI (HGNC:56660): (lncRNA TGF-beta/SMAD3 pathway interacting)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 21-36461453-G-A is Benign according to our data. Variant chr21-36461453-G-A is described in ClinVar as [Benign]. Clinvar id is 44084.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-36461453-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.306 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CLDN14NM_001146079.2 linkuse as main transcriptc.243C>T p.Arg81= synonymous_variant 2/2 ENST00000399135.6
CLDN14-AS1NR_183529.1 linkuse as main transcriptn.468+15446G>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CLDN14ENST00000399135.6 linkuse as main transcriptc.243C>T p.Arg81= synonymous_variant 2/21 NM_001146079.2 P1
CLDN14-AS1ENST00000428667.1 linkuse as main transcriptn.277+15446G>A intron_variant, non_coding_transcript_variant 5
LNCTSIENST00000429588.1 linkuse as main transcriptn.54-18778G>A intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.250
AC:
37944
AN:
152062
Hom.:
5055
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.310
Gnomad AMI
AF:
0.126
Gnomad AMR
AF:
0.228
Gnomad ASJ
AF:
0.236
Gnomad EAS
AF:
0.00771
Gnomad SAS
AF:
0.147
Gnomad FIN
AF:
0.211
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.251
Gnomad OTH
AF:
0.260
GnomAD3 exomes
AF:
0.212
AC:
52925
AN:
249378
Hom.:
6248
AF XY:
0.210
AC XY:
28388
AN XY:
135184
show subpopulations
Gnomad AFR exome
AF:
0.304
Gnomad AMR exome
AF:
0.194
Gnomad ASJ exome
AF:
0.238
Gnomad EAS exome
AF:
0.00534
Gnomad SAS exome
AF:
0.157
Gnomad FIN exome
AF:
0.206
Gnomad NFE exome
AF:
0.252
Gnomad OTH exome
AF:
0.222
GnomAD4 exome
AF:
0.242
AC:
354123
AN:
1460934
Hom.:
45244
Cov.:
36
AF XY:
0.239
AC XY:
173901
AN XY:
726808
show subpopulations
Gnomad4 AFR exome
AF:
0.309
Gnomad4 AMR exome
AF:
0.197
Gnomad4 ASJ exome
AF:
0.236
Gnomad4 EAS exome
AF:
0.00768
Gnomad4 SAS exome
AF:
0.158
Gnomad4 FIN exome
AF:
0.210
Gnomad4 NFE exome
AF:
0.259
Gnomad4 OTH exome
AF:
0.235
GnomAD4 genome
AF:
0.250
AC:
38010
AN:
152180
Hom.:
5073
Cov.:
33
AF XY:
0.243
AC XY:
18076
AN XY:
74416
show subpopulations
Gnomad4 AFR
AF:
0.310
Gnomad4 AMR
AF:
0.228
Gnomad4 ASJ
AF:
0.236
Gnomad4 EAS
AF:
0.00773
Gnomad4 SAS
AF:
0.148
Gnomad4 FIN
AF:
0.211
Gnomad4 NFE
AF:
0.251
Gnomad4 OTH
AF:
0.258
Alfa
AF:
0.254
Hom.:
3552
Bravo
AF:
0.251
Asia WGS
AF:
0.109
AC:
382
AN:
3478
EpiCase
AF:
0.251
EpiControl
AF:
0.251

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxJun 01, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 07, 2012Arg81Arg in Exon 03 of CLDN14: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 31.1% (1163/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs219779). -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Autosomal recessive nonsyndromic hearing loss 29 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 22, 2021- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.2
DANN
Benign
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs219779; hg19: chr21-37833751; COSMIC: COSV59771947; COSMIC: COSV59771947; API